Merck drug extends immune system fight to stomach cancer

Merck drug extends immune system fight to stomach cancer

By Ben Hirschler MADRID (Reuters) - Merck & Co's drug Keytruda, the first in a new wave of immune-boosting medicines to be approved for treating melanomas in the United States, also has potential in stomach cancer, new research shows. Early clinical trial results reported on Sunday mean that gastric, or stomach cancer can be added to a growing list of tumor types where so-called immunotherapy may have an important role to play. ...

Roche breast cancer drug shows 'unprecedented' survival benefit

By Ben Hirschler MADRID (Reuters) - A new breast cancer drug from Roche has shown "unprecedented" survival benefits in a clinical trial, boosting prospects for its widespread use in women with an aggressive form of the disease. Patients with a type of breast cancer known as HER-2 positive, which makes up about a quarter of all breast cancers, who were given Perjeta on top of older medicine Herceptin and chemotherapy lived 15.7 months longer than those on Herceptin and chemotherapy alone. “The survival improvement of nearly 16 months ... ...

Roche breast cancer drug shows 'unprecedented' survival benefit

By Ben Hirschler MADRID (Reuters) - A new breast cancer drug from Roche has shown "unprecedented" survival benefits in a clinical trial, boosting prospects for its widespread use in women with an aggressive form of the disease. Patients with a type of breast cancer known as HER-2 positive, which makes up about a quarter of all breast cancers, who were given Perjeta on top of older medicine Herceptin and chemotherapy lived 15.7 months longer than those on Herceptin and chemotherapy alone. “The survival improvement of nearly 16 months ... ...

No benefit from continued use of AstraZeneca's Iressa drug

By Ben Hirschler MADRID (Reuters) - Continuing to give AstraZeneca's drug Iressa plus chemotherapy to lung cancer patents whose disease has worsened after previously taking the medicine on its own does not provide any benefit. Some doctors had hoped that extending the use of Iressa in combination with chemotherapy would help to keep cancers at bay, even when tumor cells had started to develop resistance to the drug. ...

Merck drug extends immune system fight to stomach cancer

By Ben Hirschler MADRID (Reuters) - Merck & Co's drug Keytruda, the first in a new wave of immune-boosting medicines to be approved for treating melanomas in the United States, also has potential in stomach cancer, new research shows. Early clinical trial results reported on Sunday mean that gastric, or stomach cancer can be added to a growing list of tumor types where so-called immunotherapy may have an important role to play. ...

Public versus private? Swiss mull health system shift

Geneva (AFP) - Swiss voters were deciding Sunday whether to ditch the country's all-private health insurance system and create a state-run scheme, with polls indicating that they will reject the plan.

Roche breast cancer drug shows 'unprecedented' survival benefit

By Ben Hirschler MADRID (Reuters) - A new breast cancer drug from Roche has shown "unprecedented" survival benefits in a clinical trial, boosting prospects for its widespread use in women with an aggressive form of the disease. Patients with a type of breast cancer known as HER-2 positive, which makes up about a quarter of all breast cancers, who were given Perjeta on top of older medicine Herceptin and chemotherapy lived 15.7 months longer than those on Herceptin and chemotherapy alone. “The survival improvement of nearly 16 months ... ...

No benefit from continued use of AstraZeneca's Iressa drug

By Ben Hirschler MADRID (Reuters) - Continuing to give AstraZeneca's drug Iressa plus chemotherapy to lung cancer patents whose disease has worsened after previously taking the medicine on its own does not provide any benefit. Some doctors had hoped that extending the use of Iressa in combination with chemotherapy would help to keep cancers at bay, even when tumor cells had started to develop resistance to the drug. ...

You are reading an article about Merck drug extends immune system fight to stomach cancer and you can find this article in url https://we-care-you.blogspot.com/2014/09/merck-drug-extends-immune-system-fight.html,You can copy paste and use the article Merck drug extends immune system fight to stomach cancer , may this is very interesting for you and others ,but don't forget to take this link Merck drug extends immune system fight to stomach cancer for article source, Thanks.